Maternal Outcome in Pregnant Women Presenting with Preeclampsia

Kiran Safeer; Saima Gilani

doi:10.54112/bcsrj.v6i4.2276

Authors

Kiran Safeer Department of Obstetrics and Gynaecology, Rehman Medical Institute, Peshawar, Pakistan
Saima Gilani Department of Obstetrics and Gynaecology, Rehman Medical Institute, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i4.2276

Keywords:

Preeclampsia, HELLP syndrome, placental abruption, acute renal failure, maternal outcomes

Abstract

Preeclampsia is a major hypertensive disorder of pregnancy and remains an important contributor to maternal morbidity, particularly after 20 weeks of gestation. Early identification of maternal complications is essential to guide timely obstetric management. Objective: To determine the maternal outcome in pregnant women presenting with preeclampsia. Methodology: A descriptive study was conducted on 143 patients aged 18 to 40 years with gestational age > 20 weeks who presented with preeclampsia, enrolled via a non-probability, consecutive sampling technique from 05-July-2024 to 05-January-2025 in the Obstetrics & Gynecology department, Rehman Medical Institute, Peshawar. Patients with cardiovascular disease, chronic renal failure, and those who had recent abdominal surgery were excluded. Maternal outcomes were assessed, such as HELLP syndrome, placental abruption and acute renal failure. Data were analyzed using SPSS 23. Chi-square or Fisher's exact test was used for stratified analyses, with p-values ≤ 0.05 considered significant. Results: The mean age of 143 patients in this study was 28.29±6.28 years, and their mean gestational age was 32.32±5.37 weeks. HELLP syndrome was observed in 19 (13.3%) cases, placental abruption in 11 (7.7%) cases, and acute renal failure in 7 (4.9%) cases. The majority of women were from lower socioeconomic classes (42.7%), illiterate (61.5%), and unemployed (65.7%). Stratification analysis revealed no significant association of maternal outcomes with demographics (p > 0.05 for all). Conclusion: In pregnant women presenting with preeclampsia, the prevalence of HELLP syndrome was 13.3%, placental abruption was 7.7%, and acute renal failure was 4.9%.

Downloads

Download data is not yet available.

215

References

1. Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023;9(1):8. DOI: https://doi.org/10.1038/s41572-023-00417-6

2. Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341-354. DOI: https://doi.org/10.1016/S0140-6736(20)32335-7

3. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. DOI: https://doi.org/10.1136/bmj.l2381

4. Havers-Borgersen E, Fosbol E, Johansen M, Kober L, Morris JM, Seeho SKM. Pre-eclampsia in a first pregnancy and subsequent pregnancy outcomes: a nationwide cohort study. J Epidemiol Community Health. 2023;77(11):694-703. DOI: https://doi.org/10.1136/jech-2023-220829

5. Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275-289. DOI: https://doi.org/10.1038/s41581-019-0119-6

6. Giannakou K. Prediction of pre-eclampsia. Obstet Med. 2021;14(4):220-224. DOI: https://doi.org/10.1177/1753495X20984015

7. Omani-Samani R, Ranjbaran M, Amini P, Esmailzadeh A, Sepidarkish M, Almasi-Hashiani A. Adverse maternal and neonatal outcomes in women with preeclampsia in Iran. J Matern Fetal Neonatal Med. 2019;32(2):212-216. DOI: https://doi.org/10.1080/14767058.2017.1376643

8. Venkatesh KK, Strauss RA, Westreich DJ, Thorp JM, Stamilio DM, Grantz KL. Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity. Pregnancy Hypertens. 2020;20:75-82. DOI: https://doi.org/10.1016/j.preghy.2020.03.006

9. da Silva WA, Pinheiro AM, Lima PH, Malbouisson LMS. Renal and cardiovascular repercussions in preeclampsia and their impact on fluid management: a literature review. Braz J Anesthesiol. 2021;71(4):421-428. DOI: https://doi.org/10.1016/j.bjane.2021.02.052

10. Siddique U, Naeem SK, Ramejo BB, Rizwan AS, Imran M, Sahito N. Maternal outcome in women with preeclampsia. Pak J Med Health Sci. 2021;15(7):1769-1771. DOI: https://doi.org/10.53350/pjmhs211571769

11. Tabassum S, AlSada A, Bahzad N, Sulaibeekh N, Qureshi A, Dayoub N. Preeclampsia and its maternal and perinatal outcomes in pregnant women managed in Bahrain’s tertiary care hospital. Cureus. 2022;14(5):e24637. DOI: https://doi.org/10.7759/cureus.24637

12. Belay Tolu L, Yigezu E, Urgie T, Feyissa GT. Maternal and perinatal outcome of preeclampsia without severe feature among pregnant women managed at a tertiary referral hospital in urban Ethiopia. PLoS One. 2020;15(4):e0230638. DOI: https://doi.org/10.1371/journal.pone.0230638

13. Melesse MF, Aynalem GL, Badi MB, Aynalem BY. Maternal outcomes of severe preeclampsia and eclampsia and associated factors among women admitted at referral hospitals of Amhara regional state, institutional-based cross-sectional study, North-West Ethiopia. Front Glob Womens Health. 2025;6:1555778. DOI: https://doi.org/10.3389/fgwh.2025.1555778

14. Vennela M, Yeddala M, Lakshmipriya Y, Latha G. A study of maternal and perinatal outcome in severe preeclampsia and eclampsia in a tertiary care hospital. Eur J Cardiovasc Med. 2025;15(4):18-24.

15. Malhan A, Hyder M, Baloch S, Zahegul, Roshan S, Dembra G, et al. Frequency of preeclampsia in pregnant women presenting in a tertiary hospital. Pak J Health Sci. 2023;4(4):30-33. DOI: https://doi.org/10.54393/pjhs.v4i04.652